For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT03851445?term=lungmap&rank=1
LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Pulmonary
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
1384014
Study Number:
LUNGMAP
Phone:
Fax:
MK1084-012: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Gastrointestinal
Study Status:
Open to Accrual
Principal investigator:
Gang Chen, MD, PhD
IRB number :
2362784
Study Number:
G2503
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT06997497?term=kandlelit-012&viewType=Card&limit=10&sort=@relevance&rank=1
MK1084-014: A Phase 2, Open-Label, Multicenter, Tumor-agnostic Study of MK-1084 as Monotherapy and in Combination with Cetuximab in Participants with KRAS G12C Mutant, Advanced Solid Tumors (KANDLELIT-014)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Selected Cancers
Study Status:
Open to Accrual
Principal investigator:
Paul Celano, MD
IRB number :
2381957
Study Number:
G2507
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT07209111?term=MK-1084-014&rank=1
MTG022: Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Selected Cancers
Study Status:
Open to Accrual
Principal investigator:
David Gottlieb, MD
IRB number :
2039945
Study Number:
G2304
Phone:
Fax:
For more information about this specimen collection study, and specific sub-studies, please contact the clinical trials office.
NRG-BR007: A Phase III Clinical Trial Evaluating DE-escalation of Breast RAdiation (DEBRA) for Conservative Treatment of Stage I, Hormone Sensitive, HER2-Negative, Oncotype Recurrence Score < 18 Breast Cancer
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Breast
Study Status:
Open to Accrual
Principal investigator:
Kruti Patel, MD
IRB number :
1773805
Study Number:
BR007
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT04852887